Apnimed Inc. (APMD) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. In the last 30 days Quantisnow tracked 2 wire items for APMD, including 1 13D/G filing and 1 press release or news item. The most recent was published Nov 5, 2026.
APMD rankings
News · 26 weeks2+100%
2026-05-172026-11-08
Mix290d
- 13D/G1(50%)
- Other1(50%)
Activity · 52 weeks22 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
2 items- PRApnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)CAMBRIDGE, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Apnimed, Inc. (NASDAQ:APMD) ("Apnimed" or the "Company"), a late-stage clinical pharmaceutical company dedicated to the discovery, development and commercialization of novel oral therapies that address the neurobiology of sleep-related breathing diseases, today announced that on November 2, 2026, the compensation committee of Apnimed’s board of directors granted 14 new non-executive employees non-qualified stock options to purchase an aggregate of 331,000 shares of the Company’s common stock under Apnimed’s 2026 Inducement Plan (the "Plan"). Each stock option granted has an exercise price per share of $15.40, which is equal to Apnimed’s c
- 13D/GSEC Form SCHEDULE 13G filed by Apnimed Inc.SCHEDULE 13G - Apnimed, Inc. (0001745648) (Subject)
APMD FAQ
7 questionsWhat does Apnimed Inc. do?
Apnimed is a late-stage clinical pharmaceutical company dedicated to the discovery, development and commercialization of novel oral therapies that address the neurobiology of sleep-related breathing diseases. We believe the introduction of once-nightly oral drugs has the potential to expand diagnosis and the reach of treatment for people with OSA. We believe that people with OSA would benefit from having multiple treatment options with differing mechanisms to more fully address the heterogeneity of OSA's disease pathophysiology. Apnimed envisions a new era where novel oral therapies simplify...What is the latest news on APMD?
In the last 30 days Quantisnow tracked 2 wire items for APMD: 1 13D/G filing and 1 press release or news item. The most recent was published on November 5, 2026.Where does APMD stock trade?
Apnimed Inc. (APMD) is listed on NASDAQ.What sector and industry is APMD in?
Apnimed Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Apnimed Inc. go public?
Apnimed Inc. (APMD) completed its IPO in 2026.What companies are similar to APMD?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare APMD side-by-side with any of them on Quantisnow.How can I track APMD on Quantisnow?
Quantisnow aggregates Apnimed Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow APMD to receive live email and push alerts on every new disclosure.